Biofrontera, Inc. - Nilai perusahaan marang volume dodolan BFRI

Has the leader in photodynamic therapy for dermatology become an attractive asset? The enterprise value-to-revenue multiple provides the answer, where the value 312.27 reflects this status for Biofrontera Inc. (BFRI). Demand for skin cancer prevention makes the business resilient to crises; however, high marketing expenses and challenges with insurance reimbursement in the US are putting pressure on the bottom line.
Rincian metrik keuangan lan pasar Biofrontera Inc (BFRI)

Biofrontera Inc. occupies a niche in high-tech treatment of precancerous skin lesions by supplying photodynamic therapy systems to US clinics. An analysis of EV/Sales history allows for an assessment of the business value, net of debt, relative to Ameluz sales volumes, where low values may signal undervalued assets and sharp spikes may indicate a market reassessment of the company's fundamental stability.